Podcasts about Liver cancer

TODAY ON THE ROBERT SCOTT BELL SHOW: LIVE from Reno Nevada, Jonathan Emord, Bill Gates Influence Scandal, Pesticide Cancer Ruling, Joel Salatin Farm Freedom, Democrats Prefer Leaving, Vaccine Study Blowback, OB/GYN CDC LOL, Brain Death Reflections, Grocery Additives, Sugary Beverage Liver Cancer, and MORE! https://robertscottbell.com/jonathan-emord-bill-gates-nih-influence-scandal-pesticides-cancer-ruling-joel-salatin-regulatory-freedom-55-percent-of-democrats-prefer-leaving-vaccine-study-blowback-vaccine-safety-concerns-ob/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Don Dollar ignored his skin and eyes turning yellow. It was his daughter who said, "Get in the car daddy I'm taking you to the emergency room." That saved his live. That happened in February of this year 2026. After a major operation and a slow recovery, Double D is now Cancer Free and tells his amazing story.

Dr. Peter DiPasco is a surgical oncologist at Mercy Saint Louis, He joins KMOX Health Editor Fred Bodimer detailing a new sci-fi-like technique to destroy liver tumors without a single incision.

- Overview of Liver Cancer, Including Current Standard of Care - New Treatment Approaches - Clinical Trial Updates: How Research Increases Your Treatment Options - The Role of Radioembolization - Controlling Symptoms, Treatment Side Effects, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team About Your Financial Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Liver Cancer, Including Current Standard of Care - New Treatment Approaches - Clinical Trial Updates: How Research Increases Your Treatment Options - The Role of Radioembolization - Controlling Symptoms, Treatment Side Effects, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team About Your Financial Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes - Questions for Our Panel of Experts

Todays' guest is Mark Morningstar, a man with a passion for music. He's done it all, from school marching bands to Air Force Drum and Bugle Corps, to drumming in a rock band, to teaching music to high schoolers. He's also a liver cancer survivor, due to the miracle of the living liver donor program. The liver is the one organ that can regenerate and can, therefore, be donated by someone still living. Truly a miracle of modern medicine.We talk all about the living donor program and process, becoming an advocate for organ donation, healing and taking care of your health, staying positive, and so much more.If you're interested in being an organ donor, living or after death, check out the link below or register with your local DMV.Resources:Mark's Facebook: https://www.facebook.com/mark.a.morningstarMark's Instagram: https://www.instagram.com/mark.a.morningstar/Center for Organ Recovery and Education (CORE): https://core.org/Liver Education Advocates: https://liveradvocates.org/Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Beth Lehman went through a tumultuous year in 2020.  Thanks to heavy drinking, she was diagnosed with cirrhosis, then basal cell carcinoma, a type of skin cancer, followed by hepatocellular carcinoma, a form of liver cancer.  She underwent radioactive embolization in order to get a liver transplant.  Beth said the two-hour operation wasn't so tough, but the after-effects were difficult, including nausea and vomiting.  Then she experienced a procedure to get rid of the skin cancer on her right temple.  She says between her physical and emotional recovery, she advocates for cancer patients and is happier than ever.   Beth's alcohol consumption had soared to four or five bottles of wine a day.  In 2020, she began to have a buildup of fluid in her stomach, known as ascites.  For a long time, she avoided consulting a doctor, suspecting a doctor would tell her to quit drinking; but when ascites asserted itself, she sought medical attention.  She was diagnosed with cirrhosis.  Upon further examination, five tumors were discovered in her liver, which led to a diagnosis of hepatocellular carcinoma, a form of liver cancer.   This diagnosis came after another diagnosis of basal cell carcinoma, but the skin cancer had to take back seat to the liver cancer.   Beth said her care team first had to determine whether the cancer had spread beyond her liver.  Thankfully, it hadn't.  In order to complete a liver transplant, doctors wanted to execute radioactive embolization, in which radiation beads would be injected into her arteries through her wrist or groin and targeted at the tumors.  However, for that to happen, the tumors had to be 2cm, but her largest tumor was 1.87cm.  Incredibly, Beth's care team told her to go home and let the tumors grow so they would be large enough for it to go through with the radioactive embolization.   Once the tumors grew, Beth went through the procedure, also known as Y-90.  She had to go through the procedure a second time.  Usually, a second procedure comes eight to twelve weeks after the first procedure.  Beth's second procedure came just four weeks later.  She said she was awake during each procedure, each lasted about two hours, but the toughest part was post-treatment, as she had a great amount of radiation in her body, so much that upon returning home, she had to be sequestered from her husband and her pet cats. Once she recovered from her liver transplant, she had her skin cancer treated.  She said her doctors had to go seven layers deep to get all the cancer, but they did such an outstanding job that her incision is not visible.   Beth Lehman once had a lucrative IT position, but these days she works as an advocate for cancer patients, especially liver cancer patients and says she is happier than ever.   Additional Resources:   Support Groups:   The American Liver Foundation https://www.liverfoundation.org   Beth's Nonprofit, The Liver Circle https://www.thelivercircle.org   Beth's Personal Page with Her Story: https://www.bethlehmanliver.com          

Dr. Yash Singh sits down with Dr. Sudhakar Venkatesh to explore his global journey in radiology and how innovations like MR elastography are transforming the noninvasive diagnosis and staging of liver disease. They discuss the future of quantitative, AI-enhanced imaging in detecting liver cancer and biliary diseases earlier—shifting radiology from passive observation to a central, collaborative force in precision medicine. Radiology: Imaging Cancer special collection for Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine, and Hepatobiliary Cancers.

Nutritionist Leyla Muedin discusses the renaming of fatty liver disease to metabolic dysfunction-associated steatotic liver disease (M-A-S-L-D) to reduce stigma and improve diagnosis. Dr. Mary Ella's efforts at the University of Chicago Medicine highlight how this change aids in better patient identification and treatment. Leyla emphasizes lifestyle changes like a low-carb diet to manage and reverse the disease. The episode also covers the prevalence of fake extra virgin olive oil (EVOO) on the market, ways to identify authentic olive oil, and the importance of choosing quality over mass-produced options.

Join Ramtin Mojtahedi (Computing) for a discussion of his PhD research on deep learning approaches for liver cancer segmentation, tumour-type classification, and survival prediction from contrast-enhanced CT imaging. Ramtin is open to discussing his research further and can be reached at ramtin.mojtahedi@queensu.ca.

On today's episode of Beating Cancer Daily, Saranne welcomes Jacqui Bryan back to tackle one of the most requested and underappreciated health topics: how to truly love and care for your liver. With humor and heart, they uncover why the liver is a “badass” yet often overlooked powerhouse, discuss its critical role in over 500 bodily functions, and share practical strategies to keep this essential organ healthy—especially for those touched by cancer and seeking to prevent complications like metastasis to the liver. Together, they blend science-based insights with relatable stories and memorable puns, making liver health both accessible and actionable for listeners at every stage of their journey, whether coping with cancer, supporting a loved one, or simply aiming for lifelong vitality.Jacqui Bryan is a functional medicine expert extraordinaire, certified nutrition specialist, whole health educator, certified health coach, and registered nurse. Drawing from both her professional expertise and her own 22-year experience as a cancer survivor, Jacqui brings rigorous science and compassion to the conversation. She is sought-after for her guidance on holistic wellness, habit-stacking for health, and her approachable teaching style, making her a recurring favorite among Beating Cancer Daily listeners. "Your liver is involved in over 500 body functions, and you cannot survive without it." ~Jacqui Bryan Today on Beating Cancer Daily:·     Liver health is vital for everyone, but especially for cancer patients, due to the risk of metastasis and its role in detoxification.·     The liver performs over 500 crucial body functions, including metabolism, vitamin storage, immune support, and hormone regulation.·     The liver can regenerate and heal, offering hope even after periods of poor lifestyle choices or illness.·     Non-alcoholic fatty liver disease is on the rise globally, driven by obesity, poor diet, metabolic syndrome, and certain medications.·     Symptoms of liver issues can be subtle and mimic common ailments, making early detection and regular check-ups essential.·     Supporting the liver involves a plant-rich diet with fiber, healthy fats, antioxidants, choline, and B vitamins, as well as regular exercise and minimal alcohol and plastic exposure.·     The liver's function impacts mood, menopause, blood sugar, cholesterol, and inflammation levels, reinforcing its interconnectedness with overall wellness.·     Small, sustainable habit changes, like those discussed in previous habit stacking and nutrition episodes, make a significant difference in liver and whole-body health. 2025 People's Choice Podcast Awards Finalist Ranked the Top 5 Best Cancer Podcasts by CancerCare News in 2024 & 2025, and #1 Rated Cancer Survivor Podcast by FeedSpot in 2024 Beating Cancer Daily is listened to in over 130 countries across 7 continents and features over 390 original daily episodes hosted by Stage IV survivor  Saranne Rothberg.   To learn more about Host Saranne Rothberg and The ComedyCures Foundation:https://www.comedycures.org/ To write to Saranne or a guest:https://www.comedycures.org/contact-8 To record a message to Saranne or a guest:https://www.speakpipe.com/BCD_Comments_Suggestions To sign up for the free Health Builder Series live on Zoom with Saranne and Jacqui, go to The ComedyCures Foundation's homepage:https://www.comedycures.org/ Please support the creation of more original episodes of Beating Cancer Daily and other free ComedyCures Foundation programs with a tax-deductible contribution:http://bit.ly/ComedyCuresDonate THANK YOU! Please tell a friend whom we may help, and please support us with a beautiful review. Have a blessed day! Saranne

#ThisMorning | #Liver #Cancer Cases are Expected to #Double by 2050 | Hashem El-Serag, Baylor College of Medicine | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #wellness 

Gavin is joined once again by Richard and Jessamy as they examine key developments in global health and science.This week's discussion features reflections on the launch of a new Lancet series on Alzheimer's disease, highlighting advances in prevention, diagnosis, and care, as well as the ethical and practical challenges posed by emerging treatments.We also explore the global landscape of liver cancer, demographic change, the shifting centre of scientific research, and recent studies on human longevity. Join us for a thoughtful, evidence-based conversation on pressing issues in health, policy, and research worldwide.Read the full series: https://www.thelancet.com/series-do/alzheimers-diseaseRead the full commission: https://www.thelancet.com/commissions-do/hepatocellular-carcinomaSend us your feedback!Read all of our content at https://www.thelancet.com/?dgcid=buzzsprout_tlv_podcast_generic_lancetCheck out all the podcasts from The Lancet Group:https://www.thelancet.com/multimedia/podcasts?dgcid=buzzsprout_tlv_podcast_generic_lancetContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Today's guest is Tony Villiotti, founder of Liver Education Advocates, a non-profit with the mission of increasing public awareness and providing education regarding nonalcoholic liver disease. He is also a survivor of liver cancer and the beneficiary of a life-saving liver transplant.We talk all about liver disease, from diabetes to fatty liver, cirrhosis and cancer, the risk factors of all, how important it is to be monitored if you have diabetes, Tony's mission to educate the public about liver disease, lifestyle habits, and so much more!!Poor lifestyle habits can send you down this road and the symptoms are sometimes silent. This is a great reminder of how important it is to take care of your health. Resources:Websites: www.liveradvocates.org and www.higadograso.orgLinkedin: https://www.linkedin.com/company/livereducationadvocates/Instagram: https://www.instagram.com/loveyourliver1/Facebook: https://www.facebook.com/LiverEducationAdvocates YouTube: https://www.youtube.com/@LoveYourLiver1Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

Laura Koltunik from Sixmilebridge celebrated her 1st birthday at St. John's in Crumlin, having been diagnosed with Hepatoblastoma before she even turned one. A fundraiser is underway to help little Laura in her fight against cancer. Laura's dad, Adrian Fijolek, spoke with Alan Morrissey to share his daughter's story and raise awareness of her journey. You can donate here: https://www.gofundme.com/f/my-friends-11-months-she-have-cancer Photo of Laura (c) Alicja Koltunik via GoFundMe

"Make sure you do not have molds on your food because it a major cause of liver cancer because of the potential presence of aflatoxin in the molds." - Dr Asare Offei [Consultant Hepatobiliary Surgeon, KBTH]

In this episode, we explore the leading cause of cancer death worldwide, the relationship with smoking and other risk factors, types of lung cancer, screening in high-risk groups, and advances in treatment with Dr. Asare Offei.

A new report from The Lancet reveals that three out of five liver cancer cases worldwide are linked to preventable risk factors, with obesity-related cases on the rise. The analysis, published on 29th July, estimates that over 60% of liver cancers could be avoided by addressing viral hepatitis, excessive alcohol consumption, and metabolic dysfunction-associated steatotic liver disease (MASLD), a condition driven by excess fat in the liver. The situation is particularly urgent in Africa, where liver cancer cases are projected to surge significantly by 2050. In Nairobi, Ahmed Kalebi is the Principal Pathologist at Dr Ahmed Kalebi Labs. “Am I worried about metabolic liver disease being a silent epidemic? I am not just worried, I know, because we see it on a daily basis. The number of cases that we pick silently when we come for health check-ups is shocking, and we actually need to do a lot more to increase awareness for people to come for screening and a change of lifestyle. If we don't, we will be paying a huge price in the next decade to two decades, and that is why 2050 is seen as the culmination of when there will be an explosion of this liver disease associated with cancer,” he says. Professor Hashem El-Serag believes cases of Hepatitis B and C are causing the increased liver cancer rates in Africa, and that screening and vaccination in the region are lagging behind the rest of the world. However, he stresses obesity—as the continent becomes increasingly ‘westernized'—is also a major factor. “Africa is also not immune to the obesity epidemic. With the progressive westernization of their lifestyle and their diets. So, they might be hit with multiple risk factors. A leftover from the old risk factors that really are not moving fast enough. And the emergence of the new risk factors that are happening as a result of globalization,” he says. Additional measures include public awareness campaigns, improved early detection, and better integration of palliative care for patients. This article was provided by The Associated Press.

Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky  Guest: Dr. Mautin Barry-Hundeyin, MD Assistant Professor, Surgical Oncology, UK Markey Cancer Center  Cancer Conversations Episode 66 Cancer Conversations on Talking FACS Host Mindy McCulley speaks with Dr. Mautin Barry-Hundeyin, Assistant Professor of Surgical Oncology at UK Markey Cancer Center, about liver cancer—what it is, how it spreads, and why Kentucky sees higher rates. They cover primary and secondary liver cancers, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma, and major risk factors such as hepatitis B and C, alcohol, obesity/nonalcoholic steatohepatitis, and smoking. The episode reviews diagnosis and multidisciplinary care at UK Markey, plus current treatments: surgical resection and liver transplant, interventional radiology options (embolization, TACE, Y90), stereotactic body radiation, and emerging systemic therapies like targeted drugs and checkpoint immunotherapy. Listeners will learn what to expect, prevention considerations, and how to access UK Markey resources for questions and care. Connect with the UK Markey Center Online Markey Cancer Center On Facebook @UKMarkey On X @UKMarkey

#ThisMorning #Wellness | #Liver #Cancer Cases are Expected to #Double by 2050 | Hashem El-Serag, Baylor College of Medicine | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #wellness

Nutritionist Leyla Muedin reveals the alarming increase in obesity-associated cancers in the United States over the past two decades. Highlighting findings from a recent study presented at the Endocrine Society's annual meeting, Leyla underscores the significant rise in cancer deaths linked to obesity, particularly among women, older adults, Native Americans, and Black Americans. She also explores the complex causes of obesity, including genetics, lifestyle, and environmental factors, and offers insights into effective weight management strategies. Additionally, Leyla examines the high rates of heart disease in various U.S. states, emphasizing the importance of lifestyle modifications and public health initiatives to combat cardiovascular diseases.

Story at-a-glance Most people with liver damage have no symptoms and receive a diagnosis only after irreversible scarring has occurred, making early detection and lifestyle changes essential Standard blood tests often miss early-stage liver fibrosis, even when enzyme levels are "normal," delaying diagnosis until complications like cirrhosis or liver cancer appear The real threat isn't liver fat, but fibrosis — scar tissue that silently builds up from insulin resistance, inflammation, toxic fats like vegetable oils and alcohol Choline is a key nutrient that helps your liver move fat out before it causes damage; pastured egg yolks are the best source, but many people don't get enough from food alone Removing vegetable oils and alcohol, eating choline-rich foods, trimming belly fat, and moving daily help reduce liver stress and reverse fibrosis before it's too late

- Overview of Liver Cancer, Including Current Standard of Care - New Treatment Approaches - Clinical Trial Updates: How Research Increases Your Treatment Options - The Role of Radioembolization - Controlling Symptoms, Treatment Side Effects, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team About Your Financial Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments, Quality-of-Life Concerns & Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Liver Cancer, Including Current Standard of Care - New Treatment Approaches - Clinical Trial Updates: How Research Increases Your Treatment Options - The Role of Radioembolization - Controlling Symptoms, Treatment Side Effects, Discomfort & Pain - Nutrition & Hydration Concerns & Tips - Communicating with Your Health Care Team About Your Financial Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Appointments, Quality-of-Life Concerns & Discussion of OpenNotes - Questions for Our Panel of Experts

Today's guest is Beth Lehman and her story is a powerful one. She was diagnosed with alcohol related cirrhosis of the liver in 2019 and, while waiting for a transplant, was also diagnosed with liver cancer in 2020. Beth received her liver transplant in 2021 and has used her second chance to share her story, working with national organizations and speaking with current patients about the path they are walking.We talk about the emotional and spiritual layers of cancer, the complexities of liver disease, alcoholism (Beth is completely transparent), new perspectives on life, and so much more!! With grace and courage, Beth reflects on the unexpected blessings that emerged through her most difficult days, and how faith, connection and perspective carried her through.Resources:Beth's LinkedIn: https://www.linkedin.com/in/bethlehmanlivercancer/Beth's Facebook: https://www.facebook.com/beth.w.lehman.7Beth's Instagram: https://www.instagram.com/bethlehmanliver/Beth's Website: https://bethlehmanliver.com/Follow:Follow me: https://www.instagram.com/melissagrosboll/My website: https://melissagrosboll.comEmail me: drmelissagrosboll@gmail.com

The All Local 4pm for Thursday, June 6 2025

Join Salinas Valley Health interventional radiologist, Juan Rodriguez, MD, as he explores the science and promise of Y-90 radioembolization, a groundbreaking treatment reshaping the fight against liver cancer. Learn how this targeted therapy works, what the procedure entails, and its impact on managing this complex disease.

BUFFALO, NY - May 23, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 19, 2025, titled “Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma." The study, led by first authors Leonardo Gomes da Fonseca from Hospital das Clínicas, Universidade de São Paulo, Brazil, and Federico Piñero from Hospital Universitario Austral, Argentina, investigated how patients with advanced liver cancer in Latin America respond to a widely used immunotherapy combination. The researchers found that although a minority of patients developed immune-related side effects, these events did not significantly impact overall survival. Their findings highlight the importance of early recognition and careful management of such side effects in real-world clinical settings. Liver cancer is a leading cause of cancer deaths worldwide, with limited treatment options for patients diagnosed at an advanced stage. Immunotherapy, particularly the combination of atezolizumab and bevacizumab, has become a standard approach. However, these treatments can sometimes trigger the body's immune system to attack healthy organs, leading to what are called immune-related adverse events, or irAEs. Until now, little data existed on how frequently these events occur in Latin American patients and whether they impact treatment outcomes. The researchers followed 99 patients from Argentina, Brazil, Chile, and Colombia, most of whom had cirrhosis or underlying liver disease. They received atezolizumab and bevacizumab for a median duration of six months. The researchers reported that only 18% of the patients experienced immune-related side effects, most commonly affecting the liver (hepatitis) and thyroid (thyroiditis). Most of these cases were mild or moderate, and half of them resolved completely within a month. Only eight patients needed treatment with steroids to control the immune response. Importantly, the occurrence of immune-related side effects did not affect how long patients survived after starting treatment. The median survival was the same—18.5 months—for both those who experienced irAEs and those who did not. This result suggests that while irAEs require careful management, they may not reduce the overall benefits of immunotherapy. Another significant finding was that patients with higher levels of alpha-fetoprotein (AFP), a protein often elevated in liver cancer, were more likely to experience these side effects. This information could help clinicians identify patients who need closer control during treatment. “Notably, baseline alpha-fetoprotein (AFP) values ≥400 ng/ml were significantly associated with the development of irAEs.” The study also points to key differences between clinical trial results and real-world experiences. While clinical trials report higher rates of side effects, this real-world data showed a lower incidence, possibly due to less intensive monitoring or differences in how side effects are documented in everyday practice. In summary, this study highlights that patients require ongoing vigilance and individualized care when treating liver cancer with immunotherapy. It provides valuable information to healthcare providers in Latin America and other regions with similar patient populations, aiming to improve outcomes while minimizing risks. DOI - https://doi.org/10.18632/oncotarget.28721 Correspondence to - Federico Piñero - fpinerof@cas.austral.edu.ar To learn more about Oncotarget, please visit https://www.oncotarget.com. MEDIA@IMPACTJOURNALS.COM

To have your question featured in a future video, please email: questions@morses.tv Please include at least: Age, Weight and as much history as possible.

BUFFALO, NY - April 8, 2025 – A new #editorial was #published in Oncotarget, Volume 16, on April 4, 2025, titled “Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques." Dr. Yashbir Singh from Mayo Clinic and his colleagues discussed how artificial intelligence (AI) can improve liver imaging by recognizing when it might be wrong. This approach, called “uncertainty quantification,” helps clinicians better detect liver cancer and other diseases by pointing out areas in medical scans that need a second look. The authors explain how these AI tools could make imaging results more accurate and reliable, which is especially important when diagnosing serious conditions like liver tumors. Liver and bile duct imaging is difficult because of the organ's complex structure and differences in image quality. Even skilled radiologists can struggle to identify small or hidden tumors, especially in patients with liver damage or scarring. The editorial explains how new AI models not only read medical images but also measure their own confidence. When the AI system is unsure, it can alert clinicians to take a closer look. This extra layer of information can reduce missed diagnoses and improve early detection of liver cancer. One of the most advanced tools described in the editorial is called AHUNet (Anisotropic Hybrid Network). This AI model works with both 2D and 3D images and can highlight which parts of a scan it is most confident about. It performed well when measuring the entire liver and showed how its confidence dropped when scanning smaller or multiple lesions. This feature helps clinicians know when more testing or review is needed. The authors also looked at other AI models used in liver imaging. Some tools were able to analyze liver fat using ultrasound images and give clinicians both a result and a confidence score. Others improved the speed and accuracy of liver magnetic resonance imaging (MRI) scans, helping to create clear images in less time. These advancements could help hospitals work faster and provide better care. The editorial highlights how this technology can be especially helpful in smaller clinics. If they do not have liver specialists, they could still use AI systems that flag uncertain results and send them to larger centers for review. Such an approach could improve care in rural or less-resourced areas. “Radiology departments should develop standardized reporting templates that incorporate uncertainty metrics alongside traditional imaging findings.” By using AI tools that know when to second-guess themselves, clinicians may soon have more reliable methods for detecting liver cancer and monitoring liver disease. The authors suggest that uncertainty-aware AI may soon become a vital part of everyday medical imaging, supporting faster and more accurate decisions in liver disease care. DOI: https://doi.org/10.18632/oncotarget.28709 Correspondence to: Yashbir Singh — singh.yashbir@mayo.edu Video short - https://www.youtube.com/watch?v=Zm0QASQ_YSI Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28709 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords: cancer, deep learning, uncertainty quantification, radiology, hepatobiliary imaging To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, to discuss groundbreaking trials in hepatobiliary cancers, the role of diet in chronic liver disease, and the future of liver cancer care.  Timestamps:    00:00 – Introduction  02:09 – CARES-310 trial for liver cancer   4:33 – Camrelizumab + rivoceranib versus sorafenib  7:07 – Prevention and early detection of liver cancer   10:30 – Impact of lifestyle and diet on liver disease  12:38 – KEYNOTE-966 trial for biliary tract cancer  14:45 – Alternative strategies for liver cancer treatment  17:14 – Key initiatives of the International Liver Cancer Association  19:26 – Chan's three wishes for healthcare 

A study published in JAMA Internal Medicine found that statin use in patients with chronic liver disease was associated with a lower risk of liver cancer and hepatic decompensation, suggesting potential protective effects beyond lipid management. Surveys by the Annenberg Public Policy Center revealed widespread misinformation about the risks of consuming raw milk, highlighting the need for public education on the importance of pasteurization. New research links red meat allergy (alpha-gal syndrome) to bites from deer ticks and western black-legged ticks, expanding the geographic risk area and emphasizing the need for clinicians to consider this diagnosis in patients with unexplained allergic symptoms following tick bites.

Big Pharma pays billions for direct-to-consumer TV drug ads—is it time to ban them? Focused ultrasound obliterates liver tumors with minimal side effects; Nurse tricks woman into believing she's dying of cancer to cash in on her $1.5 million life insurance policy; Arizona bans insurance denial by AI automated systems; Study overturns view that very low-carb diets are bad for kidney disease patients; Strategies for reviving a lagging thyroid.

In 2021, Albertina Dancy began to experience abdominal pain, but that wasn't all.  She also had gastrointestinal issues, jaundice and other problems.  However, she didn't take them seriously and thought they could be successfully addressed with over-the-counter remedies.  When that didn't happen, she sought medical attention.   Albertina's doctor said the symptoms, combined with her existing fatty liver disease, merited a trip to an oncologist.  A series of scans and tests, plus the stiffness of her liver, led to a diagnosis of liver cancer.   The diagnosis left Albertina depressed, wondering if she would get well again.  She regrets not seeking medical attention at an earlier time because doctors said her only treatment option with a regimen of radiation treatment and chemotherapy.   The chemo was extremely tough on Albertina.  She was in constant pain, felt extreme fatigue and was demoralized about losing all her hair.   However, she achieved survivorship and says because she pays close attention to diet and exercise, her health is better than it was prior to her diagnosis.   By way of advice, Albertina Dancy strongly advises anyone suffering unusual health issues to immediately seek medical attention.   Additional Resources:   American Liver Foundation: https://www.liverfoundation,org      

In this episode, Amy Michelle Wilcockson opens her heart and shares her incredible journey of transformation—from battling thyroid cancer and liver cancer to creating the life of her dreams.Contact Amy  linktr.ee/willcocksonFor years, Amy was known as a Doctor of Chiropractic and the Director of Live Healthy Iowa, dedicated to helping others live healthier lives. But while she was focused on healing others, her own health was falling apart.The Breaking Point✅ At the peak of her career, her personal life was crumbling✅ Her mental and physical health were in crisis✅ She was diagnosed with IBS, food intolerances, hypothyroidism, Hashimoto's, a liver tumor, and thyroid cancer✅ Doctors gave her grim news—she was dying✅ She had to make a choice—keep pushing forward or fight for her lifeThe Turning Point

In this episode, host Courtney Allison discusses the latest studies on the health risks associated with alcohol use with Dr. Robert Brown, chief of Gastroenterology and Hepatology at NewYork-Presbyterian and Weill Cornell Medicine. They discuss how alcohol affects various organs, including your liver, heart, and brain, as well as its link to several cancers. Dr. Brown discusses the cultural perception of alcohol, the current guidelines around safe drinking limits, and how binge drinking harms the body. 

Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers, moderated by Dr Stephen "Fred" Divers. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/AON24).

Randy Moss' son LIVID! CURSES OUT Larry Fitzgerald Sr for LEAKING Moss' Liver Cancer diagnosis!

On so many issues, Congress has not been willing or able to act. But when faced with horrifying stories of death and mismanagement, Congress finally passed legislation to reform the US organ transplant system. They did so because people like Donna Cryer, a transplant recipient and patient advocate, demanded a better system for Americans who need lifesaving organ transplants. Now, as the new law moves into implementation, the work continues. In this episode, Donna and I discuss:The new legislation that is breaking up the deadly organ transplant monopolyHow ignoring the expertise and insights of patients dooms us to slow progress making healthcare safer and better Her advice for young people: “take your shot”Donna says we all need to start listening more closely to patients with lived experience:“I often think if you... had many people with great deals of experience and intelligence who were highly motivated to help you achieve your goal. Why would you not want to use them? Why would you not want to partner with them? Why would you work really, really hard to keep them away from solving the problem? And that's how people treat patients and patient advocates.”Relevant LinksDonna Cryer's testimony to the Senate Finance Committee on organ transplant system failures (just past the 48:00 mark)Summary of the new law to break up the organ transplantation monopolyMore about the Global Liver InstituteSee more details about the Advanced Advocacy Academy Donna's organization launchedVisit UNOS' websiteAbout Our GuestDonna R. Cryer, JD is the Founder and former Chief Executive Officer of Global Liver Institute, the only patient-driven liver health nonprofit operating across the US, EU, and UK. GLI convenes the NASH, Liver Cancer and Pediatric and Rare Liver Disease Councils, as well as the Liver Action Network, collectively more than 200 organizations.Mrs. Cryer has channeled her personal experience as a patient with inflammatory bowel disease and a 29-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. At GLI, Mrs. Cryer has raised more than $10 million for liver health initiatives. She is a frequent speaker on the topic of patient-centeredness and patient engagement in healthcare transformation and created a unique model for advocacy that mobilizes patients, influences policy, and coalesces clinicians to improve patient outcomes.Mrs. Cryer serves on the Boards of Directors for the Council of Medical Specialty Societies, Sibley Memorial Hospital/Johns Hopkins Medicine, the Innovation and Value Initiative (IVI), and the Clinical Trials Transformation Initiative. She was the first patient to serve on the ABIM Gastroenterology Specialty Board, was one of the founding members of the AASLD Patient Advisory Committee and is the Community Representative on the AASLD NASH Task Force. She has been named one of the Top Blacks in Healthcare by the Milken Institute at GW School of Public Health and BlackDoctors.org, one of the Top 10 Patients Who Make An Impact by Health 2.0 and one of PharmaVoice's 100 Most...

This episode of Walk, Don't Run to the Doctor emphasizes the importance of building and maintaining a healthy microbiome for better health outcomes, disease prevention, and overall well-being. The microbiome, a complex population of microorganisms living in the gut, plays a significant role in protecting against cancer, regulating digestion, and supporting various metabolic and immune functions. A home-cooked diet, particularly a whole food omnivorous diet rich in fiber and fermented foods, helps to cultivate a resilient microbiome. Exercise, scant to moderate alcohol consumption (especially wine), and avoiding sugar, refined flours, and artificial sweeteners further enhance gut health. This episode also warns against overuse of antibiotics and reliance on probiotic supplements, advocating instead for a food-based approach through diet and lifestyle changes. Key Takeaways: Microbiome's Role in Health: The microbiome impacts everything from cancer prevention to appetite regulation, insulin sensitivity, immune function, and even brain health. Diet and Gut Health: A Mediterranean-style, omnivorous whole food, diet improves microbiome diversity and overall health, reducing risks for conditions like obesity, diabetes, and cancer. Fermented Foods: Incorporating fermented foods like yogurt, kefir, and kombucha supports a healthy microbiome and reduces cancer risk. Exercise and Lifestyle: Regular exercise promotes gut health and boosts immunity, while avoiding sugar, artificial sweeteners, and unnecessary antibiotics helps maintain microbiome balance. Natural Approach: The podcast recommends focusing on diet and lifestyle over probiotic or prebiotic supplements to build a resilient microbiome. For more insights and advice on reducing dependence on medications through lifestyle changes, make sure to subscribe to Walk, Don't Run to the Doctor. More references can be found at www.GreatMed.org Would you like Dr. Hassell to answer your question on the air?  Contact us! Phone/text: 503-773-0770 e-mail: info@GreatMed.org Write us a letter.  We love to hear from you.  This podcast is sponsored by our generous listeners.  Send questions, comments, and support to: 4804 NW Bethany Blvd., Suite I-2, #273 Portland OR 97229 References:           Zhang, X., et al. (2023). Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights form the BE GONE trial. The Lancet, 98:104873. https://doi.org/10.1016/j.ebiom.2023.104873            Diez-Ozaeta, I. & Astiazaran, O. (2021). Fermented foods: An update on evidence-based health benefits and future perspectives. Food Research International, 156. https://doi.org/10.1016/j.foodres.2022.111133            Perler, B., et al. (2023). The role of the gut microbiota in the relationship between diet and human health. Annual Reviews in Physiology, 85:449-68. https://doi.org/10.1146/annurev-physiol-031522-092054            DeVos, W., et al. (2022). Gut microbiome and health: mechanistic insights. Gut-BMJ, 71:1020-1032. doi: 10.1136/gutjnl-2021-326789            Kim, J., and Le, H. (2022). Potential role of the gut microbiome in colorectal cancer progression.  Frontiers in Immunology, 12: 807648. doi: 10.3389/immu.2021.807648            Pyo, Y., et al. (2024). Probiotic functions in fermented foods: Anti-viral, Immunomodulatory, and anti-cancer benefits. Foods, 13:2386. https://doi.org/10.3390/foods13152386            Zhang, K., et al. (2019) Fermented dairy foods intake and risk of  cancer. International Journal of Cancer, 144: 2099-2108.            Michels, K. B., et al. (2020). Yogurt consumption and colorectal cancer incidence and mortality in the Nurses' Health Study and the Health Professionals Follow-Up Study. The American journal of clinical nutrition, 112(6), 1566–1575. https://doi.org/10.1093/ajcn/nqaa244            Shams-White, M., et al. (2022). The 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score and All-Cause, Cancer, and Cardiovascular Disease Mortality Risk: A Longitudinal Analysis in the NIH-AARP Diet and Health Study, Current Developments in Nutrition, Volume 6, Issue 6, nzac096,ISSN 2475-2991,https://doi.org/10.1093/cdn/nzac096.            Rad, A., et al. (2021). Postbiotics as promising tools for cancer adjuvant therapy. Advanced Pharmaceutical Bulletin, 11(1), 1-5. https://apb.tbzmed.ac.ir            Sharma, A., et al. Final results of a phase I/II study to investigate efficacy of a high potency multistrain probiotic on chemo induced diarrhea. ESMO, 29(8). Doi:10.1093/annonc/mdy424            Luceron-lucas-Torres, M., et al. Association between wine consumption and cancer: a systematic review and meta-analysis. Frontiers in Nutriition, 10:1197745. doi: 10.3389/fnut.2023.1197745            LeRoy, C., et al. (2020). Red  Wine Consumption  Associated with increased gut microbiota a-diversity in 3 independent cohorts. Gastroenterology, 158:270-272. https://doi.org/10.1053/j.gastro.2019.024            Duan, J., et al. (2021). The mechanisms of wine phenolic compounds for preclinical anticancer therapies. Food and Nutrition Research, 65:6507. http://dx.doi.org/10.29219/fnr:v65.6507            Zhao, L., et al. (2023). Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality. JAMA, 330(6), 537–546. https://doi.org/10.1001/jama.2023.12618            Debras, C., et al. (2022). Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLoS medicine, 19(3), e1003950. https://doi.org/10.1371/journal.pmed.1003950            Zhang, J., et al. (2019). Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut.BMJ; 68:1971-1978. doi: 10.1136/gutnl-2019-318593

In this episode, Anousha invited Mohamed Ali, a public health professional with the Seattle King County Health Department as well as a board member with Somali Health Board. Mohamed shared his experience working on the liver cancer disparities project and educating Somali communities in Seattle about the link between hepatitis B and liver cancer. Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/BTCThinkTank2024).

Join us for a discussion on the critical intersection of diabetes and liver disease. Our guest, Sarah Bauer, a pediatrician, shares her personal journey and insights into the recent screening guidelines released by the American Diabetes Association. From the importance of early detection to bridging the gap between research and practice, we explore actionable steps for improved patient care and advocacy. Sarah Bauer is a pediatrician. She discusses the KevinMD article, "Diabetes and liver disease: urgent screening needs highlighted by personal tragedy." Our presenting sponsor is Nuance, a Microsoft company. Do you spend more time on administrative tasks like clinical documentation than you do with patients? You're not alone. Clinicians report spending up to two hours on administrative tasks for each hour of care provided. Nuance, a Microsoft company, is committed to helping clinicians restore the balance with Dragon Ambient eXperience – or DAX for short. DAX is an AI-powered, voice-enabled solution that helps physicians cut documentation time in half. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. DAX Copilot can be easily enabled within the workflow of the Dragon Medical application to bring the power of ambient technology to more clinicians faster while leveraging the proven and powerful capabilities used by over 550,000 physicians. Explore DAX Copilot today. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. Discover clinical documentation that writes itself and reclaim your work-life balance. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/uhdcvq Powered by CMEfy.

Super Tuesday is underway throughout the country The U.S. Supreme Court temporarily blocked a Texas law on Monday that gives Texas law enforcement officers the ability to arrest illegal aliens entering the country from Mexico. Liver Cancer in Teens, Reduced Sexual Function, Lack of Consent: Internal Docs Reveal Experimental Nature of ‘Gender-Affirming Care': https://www.dailysignal.com/2024/03/05/liver-cancer-teens-reduced-sexual-function-lack-consent-internal-docs-reveal-experimental-nature-gender-affirming-care/ REPORT: […]

Super Tuesday is underway throughout the countryThe U.S. Supreme Court temporarily blocked a Texas law on Monday that gives Texas law enforcement officers the ability to arrest illegal aliens entering the country from Mexico. Liver Cancer in Teens, Reduced Sexual Function, Lack of Consent: Internal Docs Reveal Experimental Nature of ‘Gender-Affirming Care': https://www.dailysignal.com/2024/03/05/liver-cancer-teens-reduced-sexual-function-lack-consent-internal-docs-reveal-experimental-nature-gender-affirming-care/REPORT: Teachers Unions Quietly Spend Millions on GOP Primaries in 32 States: https://www.dailysignal.com/2024/03/04/report-teachers-unions-spend-millions-gop-primaries/On Monday, Arizona Democratic Gov. Katie Hobbs vetoed what she labeled “anti-immigrant legislation.”Independent Arizona Sen. Kyrsten Sinema announced she will not seek re-election Listen to other podcasts from The Daily Signal: https://www.dailysignal.com/podcasts/Get daily conservative news you can trust from our Morning Bell newsletter: DailySignal.com/morningbellsubscription Listen to more Heritage podcasts: https://www.heritage.org/podcastsSign up for The Agenda newsletter — the lowdown on top issues conservatives need to know about each week: https://www.heritage.org/agenda Hosted on Acast. See acast.com/privacy for more information.

We sit down with health care executive Eugene Chan to explore the rising rates of liver cancer worldwide and the potential game-changer in its treatment: monoclonal antibodies. Join us as we delve into the factors contributing to liver cancer's prevalence, the impact of vaccination, and the promising future of mAbs as a more precise and effective treatment approach. Discover the latest research on bi-specific antibodies and the ongoing efforts to improve outcomes for patients battling hepatocellular carcinoma (HCC). Eugene Chan is a health care executive. He discusses the KevinMD article, "Diversified treatments are needed to fight the increasing threat of liver cancer." Our presenting sponsor is Nuance, a Microsoft company. Together, Microsoft and Nuance are leveraging their rich digital technology and advanced AI capabilities to tackle some of health care's biggest challenges. AI-driven technology promises to revolutionize patient and provider experiences with clinical documentation that writes itself. The Nuance Dragon Ambient eXperience, or DAX for short, is a voice-enabled solution that automatically captures patient encounters securely and accurately at the point of care. DAX Copilot combines proven conversational and ambient AI with the most advanced generative AI in a mobile application that integrates directly with your existing workflows. Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 85 percent of patients say their physician is more personable and conversational. Discover AI-powered clinical documentation that writes itself. Visit https://nuance.com/daxinaction to see a 12-minute DAX Copilot demo. VISIT SPONSOR → https://nuance.com/daxinaction SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://earnc.me/FT8GkE Powered by CMEfy.